Decoration of Anti-CD38 on Nanoparticles Carrying a STAT3 Inhibitor Can Improve the Therapeutic Efficacy Against Myeloma

STAT3 is an oncoprotein which has been shown to contribute to drug resistance in multiple myeloma (MM). Nonetheless, the clinical utility of STAT3 inhibitors in treating MM has been limited, partly related to some of their pharmacologic properties. To overcome these challenges, our group had previou...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Yung-Hsing, Vakili, Mohammad Reza, Molavi, Ommoleila, Morrissey, Yuen, Wu, Chengsheng, Paiva, Igor, Soleimani, Amir Hasan, Sanaee, Forugh, Lavasanifar, Afsaneh, Lai, Raymond
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6407065/
https://www.ncbi.nlm.nih.gov/pubmed/30791634
http://dx.doi.org/10.3390/cancers11020248

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6407065/
https://www.ncbi.nlm.nih.gov/pubmed/30791634
http://dx.doi.org/10.3390/cancers11020248

Ejemplares similares